SEOUL—South Korea’s SolGent has secured an order to supply a U.S. government agency with an additional 7,500 kits which can each perform 100 CCP virus tests, the CEO of the biotech firm told Reuters.
That will double the number of tests U.S. authorities can perform using kits sourced from South Korea to 1.5 million.